1. Home
  2. MBRX vs PRSO Comparison

MBRX vs PRSO Comparison

Compare MBRX & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$3.37

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.79

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBRX
PRSO
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
13.4M
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
MBRX
PRSO
Price
$3.37
$0.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$61.00
$3.00
AVG Volume (30 Days)
327.0K
602.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
81.23
EPS
N/A
N/A
Revenue
N/A
$14,573,000.00
Revenue This Year
N/A
$18.48
Revenue Next Year
N/A
$53.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.99
52 Week Low
$0.26
$0.77
52 Week High
$7.98
$2.37

Technical Indicators

Market Signals
Indicator
MBRX
PRSO
Relative Strength Index (RSI) 69.78 33.69
Support Level $3.13 N/A
Resistance Level $5.22 $0.95
Average True Range (ATR) 0.23 0.05
MACD 0.06 -0.02
Stochastic Oscillator 87.60 10.71

Price Performance

Historical Comparison
MBRX
PRSO

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

Share on Social Networks: